Amd

This study involved nearly 2,400 adults. Almost 11 percent of them identified themselves as regular aspirin users. Eye tests were performed after five, 10 and 15 years. The researchers found that aspirin takers had twice the risk of neovascular, or “wet,” AMD in comparison to non-regular aspirin users. The findings were reported in December 2012 in the Journal of the American Medical Association.

British artificial intelligence company BenevolentAI has announced its partnership with charity group Action Against Age-related macular degeneration (AAA) to develop treatments for age-related macular degeneration (AMD), the leading cause of blindness in adults in the UK.